MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

CareDx Inc

Закрыт

СекторЗдравоохранение

14.79 0.68

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

14.56

Макс.

15.03

Ключевые показатели

By Trading Economics

Доход

1.8M

-8.6M

Продажи

2M

87M

P/E

Средняя по отрасли

14.248

37.257

Рентабельность продаж

-9.885

Сотрудники

644

EBITDA

9.3M

-4M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+45.4% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

3 нояб. 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

95M

796M

Предыдущая цена открытия

14.11

Предыдущая цена закрытия

14.79

Новостные настроения

By Acuity

17%

83%

28 / 371 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Neutral Evidence

CareDx Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

7 окт. 2025 г., 16:58 UTC

Отчет

BMW Trims 2025 View, Citing Weaker Performance in China

7 окт. 2025 г., 23:43 UTC

Обсуждения рынка

Nikkei May Trade Rangebound; Takaichi's Policy Steps in Focus -- Market Talk

7 окт. 2025 г., 23:36 UTC

Обсуждения рынка

Gold Edges Higher, Supported by Possible Hedging Demand -- Market Talk

7 окт. 2025 г., 23:19 UTC

Обсуждения рынка

Veem Can Secure More Defense Deals Following Northrop Grumman Win -- Market Talk

7 окт. 2025 г., 22:50 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

7 окт. 2025 г., 22:50 UTC

Обсуждения рынка

RBNZ Should Take the Option of a Bigger Cut -- Market Talk

7 окт. 2025 г., 22:40 UTC

Обсуждения рынка

South32's Alaskan Project Seen Starting Sooner, Worth More After U.S. Deal -- Market Talk

7 окт. 2025 г., 21:56 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

7 окт. 2025 г., 21:56 UTC

Обсуждения рынка

Australia Shares Set to Start Day Roughly Flat -- Market Talk

7 окт. 2025 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

7 окт. 2025 г., 20:44 UTC

Популярные акции

Stocks to Watch Tuesday Recap: Oracle, Dell, Trilogy Metals -- WSJ

7 окт. 2025 г., 19:42 UTC

Обсуждения рынка

Treasury Yields Fall as Data Blackout Continues -- Market Talk

7 окт. 2025 г., 19:23 UTC

Приобретения, слияния, поглощения

Private-Equity Stocks Have Gotten Crushed. J.P. Morgan Says This One Is a Buy. -- Barrons.com

7 окт. 2025 г., 19:07 UTC

Обсуждения рынка

Oil Futures Settle Mixed With Higher OPEC+ Supply in View -- Market Talk

7 окт. 2025 г., 19:02 UTC

Обсуждения рынка

U.S. Natural Gas Posts Back-to-Back Gains -- Market Talk

7 окт. 2025 г., 16:20 UTC

Обсуждения рынка

Tech, Media & Telecom Roundup: Market Talk

7 окт. 2025 г., 16:20 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

7 окт. 2025 г., 16:20 UTC

Обсуждения рынка

Home Depot Extended Pro Desk Hours Could Drive Sales Growth -- Market Talk

7 окт. 2025 г., 16:15 UTC

Обсуждения рынка

AMD's OpenAI Deal Resets Competitive Landscape for Chips -- Market Talk

7 окт. 2025 г., 16:15 UTC

Обсуждения рынка

Global Commodities Roundup: Market Talk

7 окт. 2025 г., 15:37 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

7 окт. 2025 г., 15:37 UTC

Обсуждения рынка

Markets for Canadian Aluminum Open Up Beyond U.S. -- Market Talk

7 окт. 2025 г., 15:33 UTC

Обсуждения рынка

Gold Rise Tied to Lower Confidence in Dollar Assets -- Market Talk

7 окт. 2025 г., 15:25 UTC

Обсуждения рынка

Canadian Mining Stocks Rally on U.S. Defense Dept. Deal -- Market Talk

7 окт. 2025 г., 15:15 UTC

Обсуждения рынка

Investors Look to Gold, Bitcoin as Traditional Correlations Break Down -- Market Talk

7 окт. 2025 г., 15:04 UTC

Обсуждения рынка

Market Talk Roundup: Latest on U.S. Politics

7 окт. 2025 г., 15:04 UTC

Обсуждения рынка

Canadian Aluminum Exports Squeezed by Tariffs -- Market Talk

7 окт. 2025 г., 14:56 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

7 окт. 2025 г., 14:56 UTC

Обсуждения рынка

U.S. Government Shutdown May Impact Release of Canadian Trade Data -- Market Talk

7 окт. 2025 г., 14:52 UTC

Отчет

These Stocks Are Moving the Most Today: Tesla, AMD, Ford, Dell, IBM, AppLovin, Trilogy Metals, Aehr, and More -- Barrons.com

Сравнение c конкурентами

Изменение цены

CareDx Inc Прогноз

Целевая цена

By TipRanks

45.4% рост

Прогноз на 12 месяцев

Средняя 21.33 USD  45.4%

Максимум 28 USD

Минимум 14 USD

Основано на мнении 7 аналитиков Wall Street, спрогнозировавших целевые цены для CareDx Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

7 ratings

3

Покупка

4

Удержание

0

Продажа

Техническая оценка

By Trading Central

14.77 / 18.49Поддержка и Сопротивление

Краткосрочная

Neutral Evidence

Среднесрочная

Strong Bearish Evidence

Долгосрочная

Weak Bearish Evidence

Настроения

By Acuity

28 / 371Рейтинг в Здравоохранение

Новостные настроения

Сильные свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
help-icon Live chat